Want to join the conversation?
$BMY 2Q15 Q&A: Anderson of Bernstein had a question about Opdivo pricing in Germany relative to US. Murdo explained that European thought leaders think that consistent with some perspectives with US thought leaders post ASCO, role of PD-1 is unclear in selecting patients. In Germany BMY has a public price of EUR7,421 roughly per month on July 15.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!